short acting glp 1 Short‐acting glucagon‐like peptide‐1 receptor agonists as add‐on to insulin therapy in type diabetes: A review - Albèr - 2017 - Diabetes, Obesity and Metabolism Meta-analysis comparing effects of short-and

How GLP-1 Medications Can Enhance the Effects of Intermittent Fasting Medical weight loss drugs like semaglutide and tirzepatide were originally developed to help manage type 2 diabetes, but theyve since gained widespread use for their ability to support sustainable weight loss, improve markers of metabolic health, and be used for a variety of reasons beyond weight loss

Drug selection, including whether to use either alone or in combination, is an individualized medical decision made during evaluation

Knudsen and Lau, 2019, "The discovery and development of liraglutide and semaglutide"

Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr. 2004;134(3):489-492. doi:10.1093/jn/134.3.489

But how does a weight loss drug trigger this